Comparing Tumor Cell Responses to Radiation and Drugs
Author Information
Author(s): P.R. Twentyman, G.A. Walls, K.A. Wright
Primary Institution: Medical Research Council, Clinical Oncology and Radiotherapeutics Unit
Hypothesis
Can isotope uptake assays provide a rapid and accurate assessment of tumor cell sensitivity to radiation and drugs compared to clonogenic assays?
Conclusion
The isotope uptake assay can provide a rapid quantitative assessment of cellular drug and radiation sensitivity comparable to that provided by clonogenic assay.
Supporting Evidence
- The isotope uptake assay showed good agreement with clonogenic assays for both radiation and drug responses.
- Isotope uptake curves tended to plateau at higher drug doses, indicating a limit to the assay's sensitivity.
- Clonogenic assays require longer timeframes (2-4 weeks) compared to the rapid results from isotope uptake assays.
Takeaway
This study shows that a quick test can help doctors understand how well cancer cells respond to treatments like radiation and drugs, just like a longer test does.
Methodology
The study compared the responses of tumor cells to radiation and drugs using clonogenic survival and isotope uptake assays.
Limitations
The study does not address the potential contributions of stromal cells to isotope uptake and the low plating efficiencies of tumor specimens.
Want to read the original?
Access the complete publication on the publisher's website